Efficacy of Probiotics in Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Controlled Trials
This study was designed to evaluate whether probiotics improve symptoms in patients with irritable bowel syndrome.
PubMed, Embase, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials were searched for studies that investigated the efficacy of probiotics in the management of irritable bowel syndrome. Clinical improvement was the key outcome of interest. Data were searched within the time period of 1966 through September 2007.
Eight randomized, placebo-controlled, clinical trials met our criteria and were included in the analysis. Pooling of eight trials for the outcome of clinical improvement yielded a significant relative risk of 1.22 (95 percent confidence interval, 1.07–1.4; P = 0.0042).
Probiotics may improve symptoms of irritable bowel syndrome and can be used as supplement to standard therapy.
Key wordsProbiotics Irritable bowel syndrome Meta-analysis Clinical improvement
- 2.American College of Gastroenterology Functional Gastrointestinal Disorders Task Force. Evidence-based position statement on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002;97:S1−S5.Google Scholar
- 5.Foxx-Orenstein A. IBS: review and what’s new. Med Gen Med 2006;8:20.Google Scholar
- 16.Guyonnet D, Chassany O, Ducrotte P, et al. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther 2007;26:475–86.PubMedGoogle Scholar
- 27.Jadad A. Randomised controlled trials. London: BMJ Books, 1998.Google Scholar